DUBAI, UAE, August 17, 2011 /PRNewswire/ --
Global pharmaceutical companies are currently seeking emerging markets to conduct clinical trials due to the increase in drug development costs and the demand to advance drugs faster.
The Middle East is forecasted to be one of the fastest growing markets for clinical research outsourcing based on availability of the required infrastructure, access to necessary patients, faster timelines and lower costs compared to other markets.
Clinical Trials Partnership Middle East Summit will assemble all stakeholders from leading research sites, clinical research organisations, regulators, government organisations and pharmaceutical companies to provide strategies and knowledge on critical issues such as regulatory compliance, optimising clinical trials, overcoming clinical trials challenges and identifying business opportunities in the Middle East region.
Taking place between 28th & 30th November 2011 in Dubai, this three day summit is a must for all executives, senior level directors or directors from the pharmaceutical, biotech, clinical research organisations and clinical investigators who are looking to discuss the advances of the regions clinical trials market.
Clinical Trails Partnership Middle East Summit kicks off with an essential interactive workshop on day one, looking at a comprehensive overview of 'Good Clinical Practice' in relation to the regional and international guidelines for conducting clinical trials.
The next two days are packed full of exciting and innovative discussions, crucial networking opportunities and exciting round table discussions where delegates will be able to share their views and knowledge on subjects such as 'Improving the quality of clinical trials by using standardised performance metrics'.
Event Director for Clinical Trails Partnership Middle East Summit, DoaaSaid, described the conference as'A vital event for t
|SOURCE IQPC Middle East|
Copyright©2010 PR Newswire.
All rights reserved